Showing results (331-340 of 531) with videos related to

Sort By:
Pageof 54
Blood|July 29, 1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapyJ Drach, J Ackermann, E Fritz, et al.
American Journal of Hematology|May 18, 2017
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysisSteven M Bair, Lauren Strelec, Sarah J Nagle, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2013
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patientsMeghan Karuturi, Nirav Shah, Dale Frank, et al.
Bone Marrow Transplantation|July 10, 2002
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive diseaseA D Cohen, S M Luger, C Sickles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular LymphomaBrad S Kahl, Opeyemi A Jegede, Christopher Peterson, et al.
Blood|January 18, 2003
Utility of FDG-PET scanning in lymphoma by WHO classificationRebecca Elstrom, Liang Guan, Gary Baker, et al.
Cancer Research Communications|October 11, 2024
Genomic Features of Newly Diagnosed Large B-cell Lymphoma with or without Subsequent Disease ProgressionDaniel J Landsburg, Jennifer J D Morrissette, Sunita D Nasta, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2018
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell LymphomaHua-Jay J Cherng, Rachel Lynn Sargent, Sunita Dwivedy Nasta, et al.
Brain Research Bulletin|September 23, 2015
Lifelong consumption of trans fatty acids promotes striatal impairments on Na(+)/K(+) ATPase activity and BDNF mRNA expression in an animal model of maniaVerônica T Dias, Fabíola Trevizol, Raquel C S Barcelos, et al.
Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.
Pageof 54